Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study
|Updated:2026-03-12
|
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study
解放军医学杂志(英文版)2011年26卷第6期 页码:316-323
Affiliations:
Author bio:
Funds:
Supported by the grant of Ministry of Science and Technology of the People’ s Republic of China(2008ZX10002-25);National Natural Science Foundation of China(81070359)
DOI:
中图分类号:R735.7
纸质出版:2011
Accepted:
Scan QR Code
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study[J]. 解放军医学杂志(英文版), 2011,26(6):316-323.
[1].Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study[J].Journal of Medical Colleges of PLA,2011,26(06):316-323.
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study[J]. 解放军医学杂志(英文版), 2011,26(6):316-323.DOI:
[1].Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study[J].Journal of Medical Colleges of PLA,2011,26(06):316-323.DOI:
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:retrospective randomized control study
摘要
Abstract
<
正
>
Objective:Percutaneous radiofrequency ablation(PRFA) is known to be as effective as hepatectomy for small hepatocellular carcinoma(HCC) in the long-term.We wished to ascertain how it is for recurrent small HCC.Methods:From January 2009 to November 2011
a series of sixty-one patients were included in the study according to the criteria:each patient had one recurrent HCC
less than 5 cm in diameter.Twenty-six of the 61 patients were treated with PRFA and the other 35 were treated with repeat hepatectomy.Results:The interval from first surgery to recurrent for repeat hepatectomy and PRFA groups were(1
239.60±1
017.00) d and(903.42±975.11) d respectively(P=0.066).The tumor-free time after repeat hepatectomy and PRFA were(310.23±159.50) d and(278.27±123.29) d respectively(P=0.584).Size of tumor in repeat hepatectomy and PRFA were(7.34±3.16) cm
2
and(5.59±3.40) cm
2
(P=0.215)
the total expenditure for each patient of the two groups were(26
150.66±7
923.60) yuan and(21
135.00±1
156.76) yuan(RMB)
and the time of hospitalization for each of the two groups were(15.29±4.28) d and(7.46±2.20) d(P
<
0.001).Conclusion:PRFA is proved to be as effective as repeat hepatectomy in the treatment of recurrent small HCC
and superior to repeat hepatectomy as it is less invasive.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.